News
AstraZeneca (AZN): The 0.64% AZN position was ... Data constructed from Fisher Asset Management’s 13F filings for Q4 2024 and Q1 2025. Editor's Note: This article discusses one or more ...
Q4 2024 Earnings Call Transcript May 22, 2025 Operator: Good morning and welcome to the AMSC Fourth Quarter Fiscal 2024 ...
American Superconductor Corporation ( NASDAQ: AMSC) Q4 2024 Earnings Conference Call May 22, 2025 10:00 AM ET Nicol Golez - Director of Communications Daniel McGahn - Chairman, President and Chief ...
Snipp Interactive Inc., with a market capitalization of $0.74 million, reported its Q4 2024 earnings, revealing a decline in revenue but an improvement in profitability metrics. The company posted a ...
AstraZeneca’s biologics division MedImmune is to spin out a new standalone biotech to develop six early-stage inflammation and autoimmunity programmes. To be known as Viela Bio, the spin-out ...
AstraZeneca and Honeywell are developing MDIs that will use a new propellant called HFO-1234ze, which, according to the company, has 99.9% less Global Warming Potential (GWP) than existing ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
At Teva, we are all in for better health. Increasing access to quality medicines is fundamental to improving the health of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results